Fecal Matter Transplant Shows Promise in Cirrhosis
VIENNA — Fecal microbiota transplants (FMT) helped reset gut microbiota, leading to strengthened gut barrier function and mucosal immunity in patients with cirrhosis, according to a U.K. trial. For this pilot study called PROFIT, 50 grams of liquid frozen fecal microbiota was transplanted into the jejunum via endoscopy in 22 patients while another 10 patients […]
Ukraine’s Mobile Medical Teams Duck Rockets
VIENNA — After 20 years of battling an epidemic of HIV and hepatitis fueled by injection drug use, Tetiana Deshko, PhD, woke up February 24, 2022, to a whole new challenge as director of the Kyiv-based Alliance for Public Health, Ukraine — providing services to a country torn apart by invading Russian forces and bombers. […]
‘Game Changer’ in NASH: Resmetirom Hits Endpoints in Pivotal Study
VIENNA — The investigational agent resmetirom resolved liver biopsy findings in nonalcoholic steatohepatitis (NASH) more often than placebo, according to the phase III MAESTRO-NASH trial. While 10% of placebo patients achieved resolution of inflammation, ballooning, and disease activity, the rate was 26% among people treated with the 80-mg dose of resmetirom and 30% with the […]
Young Adults With NSCLC More Apt to Get Advanced Disease Diagnosis
VIENNA — Younger adults (ages under 50) with non-small cell lung cancer (NSCLC) were significantly more likely than older adults to be diagnosed with advanced disease, a researcher said here. In 2018, 5 years after the U.S. Preventive Services Task Force recommended low-dose CT lung cancer screening (LCS) for people over age 55 — lowered […]